Background Systemic immune inflammatory index (SII) and systemic inflammatory response
index (SIRI) are combinations of non-specific inflammatory and adaptive immune response …

Objective To evaluate the prognostic value of the systemic immune-inflammatory index (SII)
for predicting in-hospital major adverse cardiovascular events (MACEs) in patients with …

Objective Prognostic indicators in acute coronary syndrome (ACS) would aid in decision-
making and identifying high-risk patients. The systemic immune-inflammation index (SII) has …

Abstract Background Systemic Inflammatory Response Index (SIRI), a composite
inflammatory marker encompassing neutrophils, monocytes, and lymphocytes, has been …

Background This study examines the predictive value of a novel systemic immune‐
inflammation index (SII, platelet× neutrophil/lymphocyte ratio) in coronary artery disease …

Background Convincing evidence suggests that inflammatory biomarkers are associated
with an increased risk among patients with acute myocardial infarction (AMI). However, the …

Background This investigation aimed to evaluate the efficacy of the Systemic Inflammatory
Response Index (SIRI) in prognosticating short-term all-cause mortality among patients …

Background Systemic immune‐inflammation index (SII) is a novel inflammatory marker
based on neutrophils, platelets and lymphocytes counts, which has potential prognostic …

Background It is well-known that systemic inflammation plays a crucial role in the
pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune …

Aim Reducing the high morbidity and mortality of ST-segment elevation myocardial
infarction (STEMI) and improving patient prognosis remains a major global challenge. This …